Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Groen, Bart ^a   Links, Thera P ^a   Lefrandt, Joop D ^a   van den Berg, Paul P ^a   de Vos, Paul ^a   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD161A ANTIGEN; LYMPHOCYTE ANTIGEN; NKR P1B ANTIGEN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; NKR-P1B PROTEIN, RAT; P-SELECTIN LIGAND PROTEIN;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECTOR CELL; FEMALE; FETUS; FETUS RESORPTION; FETUS WEIGHT; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LITTER SIZE; LYMPHOCYTE COUNT; MALE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; RAT; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; MONONUCLEAR CELL; PATHOLOGY; PREGNANCY DIABETES MELLITUS; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC;

EID: 84879268142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065490     Document Type: Article

References (51)

1. Evers IM, de Valk HW, Visser GH, (2004) Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the netherlands. BMJ 328: 915.
2. Taylor R, Davison JM, (2007) Type 1 diabetes and pregnancy. BMJ 334: 742-745.
3. [Anonymous] (1996) Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 174: 1343-1353.
4. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, et al. (1997) Prospective population based survey of outcome of pregnancy in diabetic women: Results of the northern diabetic pregnancy audit, 1994. BMJ 315: 279-281.
5. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, et al. (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: Randomised clinical trial. BMJ 337: a1680.
6. Csorba TR, Lyon AW, Hollenberg MD, (2010) Autoimmunity and the pathogenesis of type 1 diabetes. Crit Rev Clin Lab Sci 47: 51-71.
7. Veenstra van Nieuwenhoven AL, Heineman MJ, Faas MM, (2003) The immunology of successful pregnancy. Hum Reprod Update 9: 347-357.
8. Sacks GP, Studena K, Sargent K, Redman CW, (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179: 80-86.
9. van Nieuwenhoven AL, Moes H, Heineman MJ, Santema J, Faas MM, (2008) Cytokine production by monocytes, NK cells, and lymphocytes is different in preeclamptic patients as compared with normal pregnant women. Hypertens Pregnancy 27: 207-224.
10. Saito S, Nakashima A, Shima T, Ito M, (2010) Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63: 601-610.
11. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, et al. (2002) Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril 77: 1032-1037.
12. Gustafsson C, Mjosberg J, Matussek A, Geffers R, Matthiesen L, et al. (2008) Gene expression profiling of human decidual macrophages: Evidence for immunosuppressive phenotype. PLoS One 3: e2078.
13. Zhang J, Chen Z, Smith GN, Croy BA, (2011) Natural killer cell-triggered vascular transformation: Maternal care before birth? Cell Mol Immunol 8: 1-11.
14. Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A, (2007) Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 76: 30-39.
15. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, et al. (2000) Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15: 713-718.
16. Orsi NM, Tribe RM, (2008) Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol 20: 462-469.
17. Mahmoud F, Omu A, Abul H, El-Rayes S, Haines D, (2003) Lymphocyte subpopulations in pregnancy complicated by hypertension. J Obstet Gynaecol 23: 20-26.
18. Raghupathy R, Al-Azemi M, Azizieh F, (2012) Intrauterine growth restriction: Cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes. Clin Dev Immunol 2012: 734865.
19. Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM, (2010) An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 16: 510-524.
20. Leibowitz A, Schiffrin EL, (2011) Immune mechanisms in hypertension. Curr Hypertens Rep 13: 465-472.
21. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
22. Hussain MJ, Alviggi L, Millward BA, Leslie RD, Pyke DA, et al. (1987) Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined. Diabetologia 30: 907-911.
23. Wilson RG, Anderson J, Shenton BK, White MD, Taylor RM, et al. (1986) Natural killer cells in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 293: 244.
24. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, et al. (2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55: 774-779.
25. Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL, (2004) Rat models of type 1 diabetes: Genetics, environment, and autoimmunity. ILAR J 45: 278-291.
26. Visser J, Klatter F, Hillebrands JL, Jansen A, Vijfschaft L, et al. (2004) Thymectomy should be the first choice in the protection of diabetes-prone BB rats for breeding purposes. Lab Anim 38: 371-375.
27. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
28. Scriba A, Schneider M, Grau V, van der Meide PH, Steiniger B, (1997) Rat monocytes up-regulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: Monocyte subpopulations in normal and IFN-gamma-treated rats. J Leukoc Biol 62: 741-752.
29. Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S, (2005) Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174: 4081-4089.
30. Knopp RH, Warth MR, Charles D, Childs M, Li JR, et al. (1986) Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Biol Neonate 50: 297-317.
31. Lopez-Soldado I, Herrera E, (2003) Different diabetogenic response to moderate doses of streptozotocin in pregnant rats, and its long-term consequences in the offspring. Exp Diabesity Res 4: 107-118.
32. Loke YW, King A (2000) Immunological aspects of human implantation. J Reprod Fertil Suppl 55: 83-90.
33. Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J, (2012) Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 67: 311-318.
34. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, et al. (2012) The predominance of Th17 lymphocytes and decreased number and function of treg cells in preeclampsia. J Reprod Immunol 93: 75-81.
35. Hillebrands JL, Whalen B, Visser JT, Koning J, Bishop KD, et al. (2006) A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 177: 7820-7832.
36. Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E, (1998) Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 76: 147-151.
37. Karami N, Boroujerdnia MG, Nikbakht R, Khodadadi A, (2012) Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol 95: 87-92.
38. Soares MJ, Chakraborty D, Karim Rumi MA, Konno T, Renaud SJ, (2012) Rat placentation: An experimental model for investigating the hemochorial maternal-fetal interface. Placenta 33: 233-243.
39. Li J, Rabinovich BA, Hurren R, Shannon J, Miller RG, (2003) Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and-P1B. Int Immunol 15: 411-416.
40. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957-965.
41. Ahuja V, Miller SE, Howell DN, (1995) Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43. Cell Immunol 163: 59-69.
42. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
43. Ziegler-Heitbrock L, (2007) The CD14+ CD16+ blood monocytes: Their role in infection and inflammation. J Leukoc Biol 81: 584-592.
44. Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, Meisel C, (2009) Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: A prospective observational analysis. Crit Care 13: R119.
45. Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U, (2012) The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 64: 671-677.
46. Melgert BN, Spaans F, Borghuis T, Klok PA, Groen B, et al. (2012) Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One 7: e45229.
47. Sacks G, Sargent I, Redman C, (1999) An innate view of human pregnancy. Immunol Today 20: 114-118.
48. Sargent IL, Borzychowski AM, Redman CW, (2007) Immunoregulation in normal pregnancy and pre-eclampsia: An overview. Reprod Biomed Online 14 Spec No 1: 111-117.
49. de Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, et al. (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study. Arthritis Rheum 60: 3196-3206.
50. Norgaard M, Larsson H, Pedersen L, Granath F, Askling J, et al. (2010) Rheumatoid arthritis and birth outcomes: A danish and swedish nationwide prevalence study. J Intern Med 268: 329-337.
51. Baer AN, Witter FR, Petri M, (2011) Lupus and pregnancy. Obstet Gynecol Surv 66: 639-653.